Francesco Bertoni, born in Rome (Italy), 1969, married, two daughters. Medical Doctor, post-graduated in Oncology, fully devoted to cancer research, especially on the molecular biology of lymphomas and on the application of microarrays technology. Research background comprises working experiences at Bone Marrow Transplant Laboratory of the Oncology Institute of Southern Switzerland (IOSI), at the Molecular Haematology Unit of the Institute of Child Health (London, UK), at the Molecular Pharmacology Unit of the Department of Oncology at the Mario Negri Institute for Pharmacological Research (Milan, Italy) and at the Department of Experimental Haematology at the Barts And The London (London, UK).
Since April 2003, he is the principal investigator for the lymphoma lab projects and responsible for the functional genomics of the Laboratory of Experimental Oncology of the Oncology Institute of Southern Switzerland (IOSI) in Bellinzona, and since April 2007, he is also the laboratory vice-director.
His early work has largely been on immunoglobulin genes rearrangements for diagnostic and molecular follow-up purposes as well as for studying the effect of antigens on the lymphoma development. In the last years, Bertoni and his group have focused their interest on microarrays, with a particular interest on genomic profiling of lymphoid neoplasms, developing also a large International network of Collaborators.
Francesco Bertoni is the author or co-author of over 100 peer-reviewed original papers, over 25 editorial or invited reviews, over ten book sections, one edited book and over 140 abstract at national and international meetings. Since January 2009 he is the Editor-in-Chief of Hematological Oncology.